A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C

Femme et Homme

| Pays :
New Zealand
| Organes :
| Spécialités :

Extrait

A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Treatment-Naïve Adult Subjects With Genotype 1 Chronic Hepatitis C

Critère d'inclusion

Chronic hepatitis C ,CHC ,HCV ,Hepatitis C

Liens

nct
ictrp